Literature DB >> 35950938

Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era.

Gabriel Spieler1, Andrew O Westfall2, Dustin M Long2, Andrea Cherrington3, Greer A Burkholder1, Nicholas Funderburg4, James L Raper1, Edgar T Overton1, Amanda L Willig1.   

Abstract

OBJECTIVE: To examine type 2 diabetes mellitus incidence and associated risk factors among people with HIV (PWH).
DESIGN: A retrospective clinical cohort study of PWH at a Southeastern US academic HIV clinic between 2008 and 2018.
METHODS: PWH who attended at least two clinic visits were evaluated with demographic and clinical data extracted from the electronic medical record (EMR). Diabetes was defined as: hemoglobin A1C ≥6.5% and/or 2 glucose results >200 mg/dl (at least 30 days apart), diagnosis of diabetes in the EMR, or exposure to diabetes medication. Time to diabetes incidence was computed from the entire clinic population for each year. Multivariable Cox proportional hazard regression models with time-dependent covariates were created to evaluate the independent association between covariates and time to incident diabetes.
RESULTS: Among 4113 PWH, we identified 252 incident cases of diabetes. Incidence increased from 1.04 incidents per 1000 person years (PY) in 2008, to 1.55 incidents per 1000 PY in 2018. Body mass index (hazard ratio [HR] 10.5 (6.2, 17.7)), liver disease (HR 1.9 (1.2, 3.1)), steroid exposure (HR 1.5 (1.1, 1.9)), and use of integrase inhibitors (HR 1.5 (1.1, 2.0)) were associated with incident diabetes. Additional associated factors included lower CD4 + cell counts, duration of HIV infection, exposure to nonstatin lipid-lowering therapy, and dyslipidemia.
CONCLUSIONS: Rapidly increasing incident diabetes rates among PWH were associated with both traditional and HIV-related associated risk factors, particularly body weight, steroid exposure, and use of Integrase Inhibitors. Notably, several of the risk factors identified are modifiable and can be targeted for intervention.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35950938      PMCID: PMC9529800          DOI: 10.1097/QAD.0000000000003348

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  26 in total

Review 1.  Molecular mechanisms for insulin resistance in treated HIV-infection.

Authors:  Paul W Hruz
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-06       Impact factor: 4.690

2.  Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.

Authors:  Todd T Brown; Stephen R Cole; Xiuhong Li; Lawrence A Kingsley; Frank J Palella; Sharon A Riddler; Barbara R Visscher; Joseph B Margolick; Adrian S Dobs
Journal:  Arch Intern Med       Date:  2005-05-23

3.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.

Authors: 
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 19.112

4.  3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022.

Authors: 
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 19.112

5.  Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.

Authors:  Jordan E Lake; Kunling Wu; Sara H Bares; Paula Debroy; Catherine Godfrey; John R Koethe; Grace A McComsey; Frank J Palella; Katherine Tassiopoulos; Kristine M Erlandson
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

6.  Predicting diabetes risk among HIV-positive and HIV-negative women.

Authors:  Karla I Galaviz; Michael F Schneider; Phyllis C Tien; C Christina Mehta; Ighovwerha Ofotokun; Jonathan Colasanti; Vincent C Marconi; Kartika Palar; Gina Wingood; Adaora A Adimora; Maria Alcaide; Mardge H Cohen; Deborah Gustafson; Roksana Karim; Deborah Konkle-Parker; Daniel Merenstein; Anjali Sharma; Mohammed K Ali
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

7.  Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.

Authors:  Todd T Brown; Katherine Tassiopoulos; Ronald J Bosch; Cecilia Shikuma; Grace A McComsey
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

8.  Associations of General and Central Adiposity With Incident Diabetes in Chinese Men and Women.

Authors:  Fiona Bragg; Kun Tang; Yu Guo; Andri Iona; Huaidong Du; Michael V Holmes; Zheng Bian; Christiana Kartsonaki; Yiping Chen; Ling Yang; Qiang Sun; Caixia Dong; Junshi Chen; Rory Collins; Richard Peto; Liming Li; Zhengming Chen
Journal:  Diabetes Care       Date:  2018-01-03       Impact factor: 19.112

Review 9.  Weight gain and integrase inhibitors.

Authors:  Allison Ross Eckard; Grace A McComsey
Journal:  Curr Opin Infect Dis       Date:  2020-02       Impact factor: 4.968

10.  Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.

Authors:  Peter F Rebeiro; Cathy A Jenkins; Aihua Bian; Jordan E Lake; Kassem Bourgi; Richard D Moore; Michael A Horberg; W Christopher Matthews; Michael J Silverberg; Jennifer Thorne; Angel M Mayor; Viviane D Lima; Frank J Palella; Michael S Saag; Keri N Althoff; M John Gill; Cherise Wong; Marina B Klein; Heidi M Crane; Vincent C Marconi; Bryan E Shepherd; Timothy R Sterling; John R Koethe
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.